You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IgG4-related sclerosing cholangitis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multicenter Observational Study of PSC and IgG4-SC in China

Recruiting
  • Primary Sclerosing Cholangitis
  • IgG4-related Sclerosing Cholangitis
  • Only observation
  • Shanghai, 上海市, China
    RenJi Hospital
Jul 18, 2022

Detecting IgG4-related Sclerosing Cholangitis

Completed
  • IgG4-related Sclerosing Cholangitis
  • IgG4-related Disease
    • Rochester, Minnesota
    • +1 more
    Jan 3, 2022

    Autoimmune Pancreatitis, IgG4-related Sclerosing Cholangitis, Obstructive Jaundice Trial in Beijing (corticosteroids, biliary

    Unknown status
    • Autoimmune Pancreatitis
    • +2 more
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 12, 2020

    Diagnostic and Prognostic Biomarkers for IgG4-related Disease.

    Recruiting
    • Immunoglobulin G4-Related Disease
    • blood test
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 12, 2023

    IgG4-related Disease Trial (Sirolimus)

    Not yet recruiting
    • IgG4-related Disease
    • (no location specified)
    Feb 25, 2023

    IgG4 Related Disease Trial (CM310)

    Not yet recruiting
    • IgG4 Related Disease
    • CM310
    • (no location specified)
    Feb 13, 2023

    Tofatib Treatment for IgG4-related Disease

    Recruiting
    • IgG4-related Disease
    • Shanghai, Shanghai, China
      Shanghai Changhai Hospital
    Nov 15, 2022

    IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

    Recruiting
    • IgG4-related Disease With Eosinophilia
    • Beijing, Bejing, China
      Peking Union Medical College Hospital
    Mar 23, 2023

    IgG4 Related Disease Trial in United States (Obexelimab, Placebo)

    Recruiting
    • IgG4 Related Disease
    • Walnut Creek, California
    • +3 more
    Jan 27, 2023

    Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)

    Not yet recruiting
    • Autoimmune Diseases
    • placebo
    • mycophenolate mofetil
    • Beijing, China
      Peking Union Medical College Hospital
    Jul 26, 2023

    COVID-19 on Clinical Outcomes and Management of IgG4 Related

    Active, not recruiting
    • IgG4 Related Disease
    • Covid19
    • exposure to COVID19
    • Sha Tin, New Territories, Hong Kong
      Prince of Wales Hospital, The Chinese University of Hong Kong
    Nov 18, 2022

    IgG4 Related Disease, IgG4-RD Trial in Atlanta, Boston, Rochester (elotuzumab, for elotuzumab, methylprednisolone)

    Recruiting
    • IgG4 Related Disease
    • IgG4-RD
    • Atlanta, Georgia
    • +2 more
    Jul 13, 2022

    Immunoglobulin G Subclass 4 Related Disease, IgG4-related Disease, Autoimmune Pancreatitis Trial in Rochester (Rituximab,

    Completed
    • Immunoglobulin G Subclass 4 Related Disease
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jul 3, 2019

    Primary Sclerosing Cholangitis Trial in Worldwide (Volixibat, Placebo)

    Recruiting
    • Primary Sclerosing Cholangitis
    • Coronado, California
    • +36 more
    Jul 29, 2022

    Autoimmune Diseases Trial in Beijing (Drug free, IS monotherapy and GC combined with IS)

    Recruiting
    • Autoimmune Diseases
    • Drug free, IS monotherapy and GC combined with IS
    • Beijing, Beijing, China
      Beijing Friendship Hospital
    Jan 21, 2022

    IgG4-related Disease Trial in Beijing (68Ga-FAPI)

    Recruiting
    • IgG4-related Disease
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 24, 2021

    IgG4-related Disease Trial in Boston (Abatacept)

    Completed
    Has Results
    • IgG4-related Disease
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 30, 2021

    Primary Sclerosing Cholangitis Trial in Canada, Poland, United States (Seladelpar, Placebo to match Seladelpar)

    Completed
    • Primary Sclerosing Cholangitis
    • San Francisco, California
    • +9 more
    Jun 1, 2021

    IgG4 Related Disease Trial in Worldwide (Inebilizumab, Placebo)

    Recruiting
    • IgG4 Related Disease
    • Palo Alto, California
    • +81 more
    Oct 19, 2022

    Primary Sclerosing Cholangitis (PSC) Trial in Canada, United States (HTD1801, Placebo)

    Completed
    Has Results
    • Primary Sclerosing Cholangitis (PSC)
    • Chandler, Arizona
    • +25 more
    Mar 13, 2022

    Primary Sclerosing Cholangitis (PSC) Trial in Warsaw (S-Adenosyl-L-methionine (SAMe), Placebo)

    Recruiting
    • Primary Sclerosing Cholangitis (PSC)
    • S-Adenosyl-L-methionine (SAMe)
    • Placebo
    • Warsaw, Poland
      Department of Hepatology, Transplantology and Internal Medicine,
    Sep 4, 2023

    Primary Sclerosing Cholangitis Trial in Shanghai (CS0159 2mg, Placebo)

    Not yet recruiting
    • Primary Sclerosing Cholangitis
    • CS0159 2mg
    • Placebo
    • Shanghai, Shanghai, China
      Renji Hospital, Shanghai Jiao Tong University School of Medicine
    Jun 7, 2023

    Primary Sclerosing Cholangitis Trial (Aramchol meglumine)

    Not yet recruiting
    • Primary Sclerosing Cholangitis
    • Aramchol meglumine
    • (no location specified)
    Oct 17, 2023

    IgG4-related Disease Trial in Beijing (Prednisone and Belimumab, Prednisone)

    Recruiting
    • IgG4-related Disease
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 6, 2021

    Primary Sclerosing Cholangitis Trial in Paris, Monza, Barcelona (A3907)

    Recruiting
    • Primary Sclerosing Cholangitis
    • Paris, France
    • +2 more
    Jan 27, 2023